Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,813 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identifying Health Economic Considerations to Include in the Research Protocol of a Randomized Controlled Trial (the REDUCE-RISK Trial): Systematic Literature Review and Assessment.
Neyt M, Christiaens A, Aloi M, de Ridder L, Croft NM, Koletzko S, Levine A, Turner D, Russell RK, Ruemmele FM, Veereman G. Neyt M, et al. Among authors: turner d. JMIR Form Res. 2021 Jan 25;5(1):e13888. doi: 10.2196/13888. JMIR Form Res. 2021. PMID: 33492239 Free PMC article. Review.
Clostridium difficile and pediatric inflammatory bowel disease: a prospective, comparative, multicenter, ESPGHAN study.
Martinelli M, Strisciuglio C, Veres G, Paerregaard A, Pavic AM, Aloi M, Martín-de-Carpi J, Levine A, Turner D, Del Pezzo M, Staiano A, Miele E; Porto IBD Working Group of European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN). Martinelli M, et al. Among authors: turner d. Inflamm Bowel Dis. 2014 Dec;20(12):2219-25. doi: 10.1097/MIB.0000000000000219. Inflamm Bowel Dis. 2014. PMID: 25268634
Use of Biosimilars in Paediatric Inflammatory Bowel Disease: A Position Statement of the ESPGHAN Paediatric IBD Porto Group.
de Ridder L, Waterman M, Turner D, Bronsky J, Hauer AC, Dias JA, Strisciuglio C, Ruemmele FM, Levine A, Lionetti P; ESPGHAN Paediatric IBD Porto Group. de Ridder L, et al. Among authors: turner d. J Pediatr Gastroenterol Nutr. 2015 Oct;61(4):503-8. doi: 10.1097/MPG.0000000000000903. J Pediatr Gastroenterol Nutr. 2015. PMID: 26154031
Use of Placebo in Pediatric Inflammatory Bowel Diseases: A Position Paper From ESPGHAN, ECCO, PIBDnet, and the Canadian Children IBD Network.
Turner D, Koletzko S, Griffiths AM, Hyams J, Dubinsky M, de Ridder L, Escher J, Lionetti P, Cucchiara S, Lentze MJ, Koletzko B, van Rheenen P, Russell RK, Mack D, Veereman G, Vermeire S, Ruemmele F. Turner D, et al. J Pediatr Gastroenterol Nutr. 2016 Jan;62(1):183-7. doi: 10.1097/MPG.0000000000001024. J Pediatr Gastroenterol Nutr. 2016. PMID: 26545204
New treatments for ulcerative colitis: do we have pediatric data?
Russell RK, Hansen R, Turner D. Russell RK, et al. Among authors: turner d. Expert Rev Clin Immunol. 2016 Jul;12(7):701-4. doi: 10.1080/1744666X.2016.1177459. Epub 2016 Apr 26. Expert Rev Clin Immunol. 2016. PMID: 27074695 No abstract available.
3,813 results